Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Modern therapy for dementia].

F Padberg1, H J Möller, R Bottlender

  • 1Oberarzt der Klinik fur Psychiatrie und Psychotherapie, LMU München. padberg@med.uni-muenchen.de

MMW Fortschritte Der Medizin
|June 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated photosynthetic potential in Polylepis reticulata trees from the Andean tree line.

Plant biology (Stuttgart, Germany)·2025
Same author

Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States.

The journal of prevention of Alzheimer's disease·2024
Same author

Aggressive intentions after social exclusion and their association with loneliness.

European archives of psychiatry and clinical neuroscience·2022
Same author

Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease.

The journal of prevention of Alzheimer's disease·2022
Same author

Attachment mediates the link between childhood maltreatment and loneliness in persistent depressive disorder.

Journal of affective disorders·2022
Same author

Transcranial Direct Current Stimulation (tDCS) for major depression - Interim analysis of cloud supervised technical data from the DepressionDC trial.

Brain stimulation·2021
Same journal

MMW Fortschritte der Medizin·2026
Same journal

MMW Fortschritte der Medizin·2026
Same journal

MMW Fortschritte der Medizin·2026
Same journal

MMW Fortschritte der Medizin·2026
Same journal

MMW Fortschritte der Medizin·2026
Same journal

MMW Fortschritte der Medizin·2026
See all related articles

Cholinesterase inhibitors show effectiveness for Alzheimer disease, vascular dementia, and dementia with Lewy bodies. Treatment also addresses behavioral disorders common in moderate to severe dementia stages.

Area of Science:

  • Neurology
  • Pharmacology

Context:

  • Alzheimer disease (AD), vascular dementia (VD), and dementia with Lewy bodies (DLB) are common dementia diagnoses.
  • Current AD treatments include cholinesterase (ChE) inhibitors and memantine.
  • VD therapy focuses on primary disease management and preventing cerebrovascular accidents.

Purpose:

  • To review the current treatment landscape for major dementia types.
  • To highlight the potential of ChE inhibitors for VD and DLB.
  • To emphasize the importance of managing non-cognitive symptoms in dementia.

Summary:

  • ChE inhibitors and memantine are standard for AD treatment.
  • While not FDA-approved for VD and DLB, ChE inhibitors demonstrate efficacy in clinical studies for these conditions.
  • Non-cognitive symptoms, or behavioral disorders, are prevalent and require specific treatment, with newer medications replacing older ones.

Related Experiment Videos

Impact:

  • Suggests ChE inhibitors could be beneficial for a wider range of dementia patients.
  • Underscores the need for comprehensive dementia care, including management of behavioral disturbances.
  • Informs clinical practice regarding medication choices for dementia and associated symptoms.